Back to Journals » Core Evidence » Volume 9

Core Evidence


Archive: Volume 9, 2014

Luliconazole for the treatment of fungal infections: an evidence-based review

Khanna D, Bharti S

Core Evidence 2014, 9:113-124

Published Date: 24 September 2014

Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis

Coimbra S, Figueiredo A, Santos-Silva A

Core Evidence 2014, 9:89-97

Published Date: 21 July 2014

Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review

Buckley MS, Berry AJ, Kazem NH, Patel SA, Librodo PA

Core Evidence 2014, 9:71-80

Published Date: 20 June 2014

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]

Vaishampayan UN

Core Evidence 2014, 9:69-70

Published Date: 16 May 2014

Development of cabozantinib for the treatment of prostate cancer

Vaishampayan UN

Core Evidence 2014, 9:61-67

Published Date: 23 April 2014

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]

Shah I, Khan SO, Malhotra S, Fischell T

Core Evidence 2014, 9:49-50

Published Date: 14 March 2014

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis

Di Franco M, Gerardi MC, Lucchino B, Conti F

Core Evidence 2014, 9:41-48

Published Date: 12 March 2014

Micafungin: an evidence-based review of its place in therapy

de la Torre P, Reboli AC

Core Evidence 2014, 9:27-39

Published Date: 25 February 2014

Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis

Clark O, Botrel TE, Paladini L, Ferreira MB

Core Evidence 2014, 9:1-11

Published Date: 6 January 2014